Novo Nordisk is expanding its tabletting facility in Monksland, Athlone, Ireland with a 432 million euro ($372.5 million) ...

Bagsværd, Denmark, 2 March 2026 - Novo Nordisk today announced an investment of 432 million euro (approx. DKK 3.2 billion) in ...

Both Novo and obesity market rival Eli Lilly have outlaid significant funds to ensure future demand for oral weight loss ...

Novo Nordisk has said it will invest DKK 3.2 billion (€432 million) in a manufacturing plant in Ireland that will be used to ...

Too early to say if €400m investment will result in more permanent jobs for the county - News - Roscommon Herald ...

Novo Nordisk has announced it will invest 432m euros in its facility in Ireland. The tabletting facility, in Monksland, Athlone, will provide significant additional manufacturing capacity for current ...

Weight-loss drug pioneer Novo Nordisk will invest €432 million in upgrading its Athlone plant to produce the tablet form of its Wegovy therapy. The company said the Irish tabletting facility would ...

Novo Nordisk has today announced an investment of €432 million in its facility in Monksland, Athlone. This tabletting ...

Novo Nordisk today announced an investment of 432 million euro ($510 million) in its facility in Monksland, Athlone, Ireland. This tabletting facility will provide significant additional manufacturing ...